Abstract. Conophylline and betacellulin-δ4 reproduce differentiation-inducing activity of activin A and betacellulin, respectively. We examined the effect of conophylline and betacellulin-δ4 on β cell differentiation. In AR42J cells, conophylline and betacellulin-δ4 converted them into insulin-producing cells. Cells treated with conophylline and betacellulin-δ4 continued to grow after differentiation. Thus, cell number and insulin content were much greater compared to cells treated with activin A and betacellulin. Furthermore, cells treated with conophylline and betacellulin-δ4 secreted insulin in response to glucose. Likewise, conophylline and betacellulin-δ4 converted pancreatic ductal cells into insulin-producing cells. Insulin content, cell number and glucose-evoked insulin secretion were significantly greater than those in cells treated with activin A and betacellulin. Transplantation of pseudoislets prepared using ductal cells treated with conophylline and betacellulin-δ4 was able to reduce effectively the plasma glucose concentration in streptozotocin-treated nude mice. Conophylline and betacellulin-δ4 are effective in inducing differentiation of β cells from progenitors.
A remarkable step made recently in the field of islet cell biology is the establishment of the method for induction of differentiation of β cell precursors in vitro and conversion of progenitors to insulin-secreting cells. Pancreatic ductal cells obtained from mice and human cadaveric donors [1] [2] [3] can thus be converted to insulin-secreting cells in a culture system. Precursor cells obtained from pancreatic islets are also convertible to insulin-secreting β cells [3, 4] . Stem cells or progenitor cells in other tissues are other candidates for the source of β cells. For example, stem cells in the liver, intestine and bone marrow [5] [6] [7] [8] [9] [10] [11] convert to insulin-secreting cells under appropriate conditions. In addition to these somatic stem cells, embryonic stem cells can be differentiated to insulin-producing cells [12, 13] . These technologies will enable a new therapeutic approach for β cell transplantation in the near future, in which β cells differentiated from progenitor cells in vitro are transplanted to diabetic patients. To achieve this goal, there are still many hardles to overcome. Indeed, it is necessary to establish a method to obtain a large number of well-differentiated insulinproducing cells in vitro. Practically, this is rather difficult and additional information is still needed to solve these issues. Among them, factors capable of inducing β cell differentiation effectively are quite important for in vitro conversion of progenitor cells to β cells.
We previously reported that activin A and betacellulin (BTC) induced differentiation of pancreatic AR42J cells, a model cell system of pancreatic precursor cells, and converted them to insulin-secreting cells [14] . Subsequently, BTC was shown to promote regeneration of β cells in vivo [15] [16] [17] [18] , and activin A also enhanced the effect of BTC on β cell regeneration [18] . A combination of activin A and BTC was also capable of inducing differentiation of pancreatic ductal cells obtained from neonatal rats and converting them to β cells [19] . β cells thus obtained by the treatment with activin A and BTC were able to reverse hyperglycemia in streptozotocin (STZ)-treated nude mice [19] . To obtain more potent and effective factors, we started a search for such agents using AR42J cells as a model system. We found that conophylline (CnP), a vinca alkaloid purified from a tropical plant in Thailand [20] , reproduced the differentiation-inducing activity of activin A [21] . CnP is unique in that, unlike activin A, its apoptosis-inducing activity is minimal [21, 22] . In this sense, CnP is a differentiation factor of pancreatic endocrine cells, which induces expression of neurogenin-3 [21] . On the other hand, we found recently that BTC-δ4, a short form variant of BTC, has a unique action in pancreatic progenitor cells [23] . BTC-δ4 is a protein product of a splicing variant of the BTC gene lacking exon 4, which lacks the epidermal growth factor (EGF) motif. Despite the absence of the EGF-motif, BTC-δ4 is biologically active and induces differentiation. It is as potent as or probably more potent than BTC in inducing differentiation of β cells both in vitro and in vivo. Unlike BTC, however, BTC-δ4 does not bind to and activate ErbB-1 and ErbB-4 and thereby does not promote cell growth [23] . In this regard, BTC-δ4 is a differentiation factor for β cells [23] . It is expected that a combination of CnP and BTC-δ4 would be as effective as a combination of activin A and BTC. In the present study, we examined the effect of the combination of CnP and BTC-δ4 and compared it to the effect of the combination of activin A and BTC. The results show that the combination of CnP and BTC-δ4 is much more effective in inducing differentiation of β cells than expected and thus makes it possible to obtain a large number of β cells in vitro.
Materials and Methods

Materials
Recombinant human activin A was provided by Dr. Y. Eto (Central Research Laboratory, Ajinomoto Inc., Kawasaki, Japan). CnP was extracted from the leaves of Ervatamia microphylla and purified as described elsewhere [20] . Recombinant human BTC and BTC-δ4 were prepared as described previously [23, 24] .
Cell culture
Pancreatic AR42J-B20 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (Gibco BRL, GrandIsland, NY) as described previously [14] . To induce differentiation, cells were cultured for the indicated period in DMEM containing 10% serum and a combination of activin A and BTC or a combination of conophylline and BTC-δ4.
For the culture of ductal cells, pancreatic ducts were hand-picked from seven-day old male Wistar rats after collagenase digestion of the pancreas [25] . Ductal cells were dispersed by using Dispase (Godo Shuzo, Tokyo, Japan). Cells were then cultured in DMEM containing 0.1% serum for ten days [19] . To induce differentiation, ductal cells were incubated in DMEM containing 0.1% serum and a combination of Cnp and BTCδ4 for various periods.
Measurement of mRNA expression
Total RNA was extracted by using TRIzol Reagent (Invitrogen Japan, Tokyo, Japan). Messenger RNA was extracted using the Quick Prep Kit (Pharmacia LKB Biotechnology, Piscataway, NJ). Messenger RNA samples were pretreated with DNase to remove contamination of genomic DNA. First-strand cDNA was synthesized using a Preamplification System for SUPERSCRIPT First-Strand Synthesis System (Invitrogen Japan). Reverse-transcription PCR (RT-PCR) was performed as described previously [25] . Real-time PCR was performed by the ABI Prism 7700 Sequence Detection System using SYBR Green PCR Core Reagent Kit (Perkin-Elmer Applied Biosystem, Foster City, CA). Reactions included 5 µl of a 10 × SYBR PCR buffer, 2 µl MgCl 2 (50 mM), 1 µl dNTP mix, 1 µl 3'-primer, 1 µl 5'-primer, 0.5 Amplitaq Gold and 1 µl cDNA. Samples were incubated at 94°C for 5 min, followed by the indicated cycles of 30 sec at 94°C, 4 sec at 60°C, 45 sec at 72°C, and final extension at 72°C for 10 min. The expression of rat insulin, pancreatic polypeptide (PP) somatostatin and GAPDH in each sample was quantified in separate tubes with the following primers: rat insulin (sense: 5'-GGCTTTTG TCAAACAGCACCTTTG3'; antisense 5'-AGTTGC AGTAGTTCTCCAGTTGG-3'), rat PP (sense: 5'-TG AACAGAGGGCTCAATACGAAAC-3'; antisense: 5'-AGACAGATTGCTGTCGCCATATTC-3'), rat GAPDH (sense: 5'-CATGACCACAGTCCATGCCA TC-3'; antisense: 5'-CACCCTGTTGCTGTAGCCAT ATTC-3'). No PCR products were detected in the RT-PCR procedure without reverse transcription.
Measurement of membrane potential
Changes in the membrane potential were measured by cell-attached mode of perforated patch clamp under the current clamp conditions as described previously [26] . All data were obtained using a computer-based amplifier system (EPC-9) controlled by E9 screen software (HEKA, Lambrecht, Germany). The cell membrane was perforated using Amphotericin B (Sigma). The extracellular solution contained 137 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 5 mM NaHCO 3 , 2.7 mM glucose and 10 mM Hepes/NaOH (pH 7.4). The standard patch electrode solution contained 95 mM potassium-aspartate, 40 mM KCl, 5 mM NaCl, 1 mM MgCl 2 and 10 mM Hepes/N-methyl-Dglucamine (pH 7.2).
Measurement of insulin
Insulin was measured by time-resolved immunofluorometric assay as described previously [14] . To measure the insulin content, insulin was extracted by using cold acid/ethanol, heated for 5 min in 70°C water bath, centrifuged and the supernatant was stored at -20°C until assay.
Measurement of changes in the cell number
Changes in the cell number were assessed by using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] [27] . After incubation for the indicated period, cells were treated with MTT for 3 h at a final concentration of 1 mg/ml. MTT metabolized to formazan was determined spectrophotometrically.
Formation of pseudoislets
Ductal cells were incubated for five to seven days with 100 pg/ml conophylline and BTC-δ4. Differentiated cells were dispersed by trypsin digestion. Cells (5 × 10 5 cells/ml) were cultured in a gelatin-coated dish in medium containing 100 µg/ml conophylline and BTC-δ4 under constant stirring (30 rotation per min) as reported previously [19] .
Transplantation of pseudoislets
Four week-old nude mice were injected peritoneally with 150 µg/g streptozotocin (STZ) (day 0). On day 2, pseudoislets were injected into the portal vein, and the random plasma glucose concentration was measured daily between 14:00 and 16:00. On days 5, 10, 20 and 30, the plasma insulin concentration was measured. On day 30, an intraperitoneal glucose loading test was performed [18] .
Results
Effect of CnP and BTC-δ4 on differentiation of AR42J cells
We first examined the effect of CnP and BTC-δ4 on differentiation of AR42J cells and compared it to that induced by the combination of activin A and BTC. When these cells were incubated in serum-containing medium with a combination of activin A and BTC, they stopped growing and converted to insulin-producing cells [14] . Similarly, most of the AR42J (more than 90%) converted to insulin-producing cells when cultured with a combination of CnP and BTC-δ4. Unlike the treatment with activin A and BTC, however, cells treated with CnP and BTC-δ4 continued to grow after they differentiated to insulin-producing cells. Fig. 1A depicts the changes in the cell number after the treatment with either a combination of activin A and BTC or a combination of CnP and BTC-δ4. When treated with activin A and BTC, cells stopped growing and the cell number was actually reduced after 3 days. In contrast, cells treated with CnP and BTC-δ4 continued to grow. Thus, the cell number after the treatment with CnP and BTC-δ4 was markedly greater. Fig. 1B dem- onstrates the changes in the insulin content. When cells were treated with a combination of activin A and BTC, insulin was detectable after 3 days, but it became undetectable thereafter. In sharp contrast, the insulin content of the cells treated with CnP and BTC-δ4 increased as a function of time and was much greater than that of the cells treated with activin A and BTC. We then examined the insulin secretory response of AR42J cells. As reported previously [14] , cells treated with activin A and BTC responded to both tolbutamide and glucagon-like peptide-1 (GLP-1), and insulin secretion was augmented by these agents. However, they did not respond to a high concentration of glucose (16.7 mM), a primary secretagogue of insulin. In cells treated with CnP and BTC-δ4, insulin responses to tolbutamide was nearly identical to those treated with activin A and BTC. Indeed, these cells acquired the responsiveness to a high concentration of glucose. Thus, insulin secretion increased more than two-fold in the presence of 16.7 mM glucose ( Fig. 2A) . Fig. 2B shows the changes in the membrane potential of the differentiated cell in response to the high concentration of glucose. As can be seen, glucose induced a gradual depolarization of the plasma membrane, which was followed by a burst of action potential. To further determine the effect of CnP and BTC-δ4 on differentiation of AR42J cells, we measured the expression of GLUT2, glucokinase, SUR1 in cells treated with activin A and BTC and CnP and BTC-δ4. GLUT2 was expressed in naïve AR42J cells. As reported previously, treatment with activin A and BTC induced the expression of SUR1 [14] . The expression of glucokinase was slightly detected in cells treated with activin A and BTC, but increased in cells treated with CnP and BTC-δ4 (Fig. 3) .
We reported previously that p38 and p42/44 mitogen activated protein kinases were critical for activin A and BTC-induced differentiation [28] [29] [30] , respectively. We therefore studied the effects of CnP and BTC-δ4 on p38 and p42/44 MAP kinases and compared them to those of activin A and BTC. As shown in Fig.  4 , a combination of CnP and BTC-δ4 activated both p38 and p42/44 MAP kinases. Although the time course of activation was slightly different, two combinations elicited activation of the two kinases to similar extents. Changes in the membrane potential in response to 11 mM glucose was measured by patch clamp using current clump. Fig. 3 . Changes in the Expression of mRNA for GLUT2, SUR1 and Glucokinase AR42J cells were treated with either a combination of 1 nM activin A and 1 nM BTC or a combination of 100 ng/ml CnP and 1 nM BTC-δ4 for 3 days. Expression of mRNA for GLUT2, SUR1 or glucokinase (GK) was measured by RT-PCR. 
Effect of CnP and BTC-δ4 on differentiation of pancreatic ductal cells
We next studied the effect of CnP and BTC-δ4 on differentiation of pancreatic ductal cells obtained from neonatal rats. Incubation of the ductal cells with CnP and BTC-δ4 converted them to insulin-producing cells. Fig. 5A shows the changes in the expression of mRNA for insulin in cells treated with CnP and BTC-δ4. As can be seen, mRNA for insulin was not detectable before the treatment but became detectable two days after the treatment. mRNA for insulin increased as a function of time. mRNA for somatostatin became detectable two days after the treatment, peaked three days after the treatment and decreased thereafter (data not shown). Note that mRNA for glucagon was not detectable before or after the treatment. Fig. 5B demonstrates the changes in the cell number after the treatment with CnP and BTC-δ4. The cell number increased even after most of the cells became insulin- positive. Similarly, the insulin content of the cells increased as a function of time (Fig. 5C ). Fig. 5D shows the insulin secretory response of the cells treated with CnP and BTC-δ4. In cells treated with CnP and BTC-δ4, a depolarizing concentration of potassium, tolbutamide and GLP-1 increased insulin secretion. Furthermore, 16.7 mM glucose induced an approximately two-fold increase in insulin secretion. We next prepared pseudoislets using cells treated with CnP and BTC-δ4 by incubation for five days [19] . The diameter of the pseudoislets was 110 ± 25 µm (n = 10). Fig. 6 demonstrates the insulin secretion from pseudoislets. As depicted, the insulin secretory response of the pseudoislets was much greater compared to those obtained in differentiated cells cultured in the monolayer. In particular, the insulin response to high concentration of glucose was more than 400% of the basal.
Transplantation of pseudoislets
We then transplanted 100 pseudoislets into the portal vein of the STZ-treated nude mice. As shown in Fig. 7 , the plasma glucose concentration in STZ-treated mice was higher than 400 mg/dl. When the pseudoislets were transplanted, the plasma glucose concentration decreased markedly and remained reduced for at least four weeks. The plasma insulin concentrations measured on day 5 and day 10 were 2.3 ± 1.0 ng/ml (n = 5) and, 2.0 ± 0.8 ng/ml (n = 5), respectively. To determine the outcome of the transplanted pseudoislets, we searched for pseudoislets in the liver 1 and 4 weeks after transplantation by staining the liver slices with anti-insulin antibody. However, no pseudoislets were found in the slices.
Discussion
In the previous study, we showed that CnP reproduced the effect of activin A on differentiation of AR42J cells [22] . CnP is as potent as activin A in inducing differentiation but it had little apoptosisinducing activity [21] . On the other hand, BTC-δ4 reproduced the action of BTC whereas BTC-δ4 was weak in blocking apoptosis [23] . In fact, when BTC-δ4 and activin A were added to AR42J cells, these cells differentiated into insulin-producing cells but most of them died by apoptosis due to the apoptosis-inducing activity of activin A [23] . It is thus expected that a combination of CnP and BTC-δ4 would be as effective as a combination of activin A and BTC.
The results of the present study show that, in AR42J cells, the combination of CnP and BTC-δ4 is advantageous in many respects the combination of activin A and BTC. First, cells cultured in the presence of serum continued to grow even after they became insulinpositive. This is a great advantage when obtaining a large number of differentiated cells in vitro. Second, the insulin content increased as a function of time; and thirdly, cells acquired glucose-responsiveness. In general, growth and differentiation are thought to be opposite phenomena and mutually exclusive. However, this is not the case in many situations in vivo. For example, β cells grow in normal conditions, albeit at a low rate [31] . In vivo, these cells continue to grow expressing differentiated functions at least in some conditions [32] . Although the precise mechanism is unclear at present, the combination of CnP and BTCδ4 induces proliferation maintaining at least some differentiated functions in AR42J cells. After conversion to insulinproducing cells, the increase in the insulin content is roughly proportional to the increase in the cell number. In this regard, the increase in the insulin content is due largely to proliferation of differentiated cells. However, CnP and BTC-δ4 not only stimulated proliferation of differentiated cells but they also induced maturation of insulin-producing cells. Thus, cells acquired responsiveness to glucose after the treatment with CnP and BTC-δ4: they depolarized and produced action potentials when the ambient glucose concentration was elevated and insulin secretion was augmented. Induction of the glycokinase gene may have been critical for the acquirement of glucose responsiveness. We reported previously that CnP activated p38 mitogen-activated protein (MAP) kinase [21] . Given that p38 plays a critical role in inducing neurogenin 3 gene [29] , CnP may induce differentiation by activating p38. We showed previously that transfection of constitutively active p42/44 MAP kinase induced differentiation, and conversely, transfection of MAP kinase phosphatase blocked differentiation [28] . These results led to the conclusion that activation of p42/44 MAP kinase is critical in the action of BTC on differentiation [28] . In contrast to BTC, BTC-δ4 lacks the C-loop of the EGF motif [23] and thereby is not able to bind to the ErbB1 and ErbB4 [23] . Presumably, BTC-δ4 binds to a receptor different from the ErbB1 or ErbB4 and exerts its action via the unique receptor [33] . We found recently that BTC-δ4 activates p42/44 MAP kinase by a mechanism different from that of BTC (Ishiyama N and Kojima I, unpublished observation). Further studies are necessary to determine the mechanism of action of BTC-δ4. Results shown in Fig. 4 reveal that the combination of CnP and BTC-δ4 reproduces the effect of activin A and BTC on p42/44 and p38 MAP kinases. This is the basis for the differentiation-inducing activity of CnP and BTC-δ4. However, the difference in the growth-promoting activity in the two combinations cannot be explained by these observations. In this regard, it should be mentioned that activin A has strong growth-inhibiting and proapoptotic actions [14, 28] . The difference in the growth properties of the cells treated with the two combinations may largely result from activin A. In other words, activation of the Smad system by activin A may be responsible for the different action of the two combinations on cell growth. In any event, the combination of CnP and BTC-δ4 provides a useful tool to induce differentiation of pancreatic precursor cells.
The combination of BTC-δ4 and CnP was effective in inducing differentiation of pancreatic ductal cells. Although these cells converted to insulin-secreting cells by activin A and BTC, the number of differentiated cells obtained was relatively low. This was perhaps due to the growth-inhibiting action of activin A. In contrast, differentiated cells continued growing when they were treated with CnP and BTC-δ4. Consequently, the number of insulin-secreting cells obtained was much greater. This is a great advantage when obtaining a large number of β cells in vitro for transplantation. As shown in Fig. 6 , the greater the number of pseudoislets transplanted, the better was the glycemic control. As shown in human islet transplantation [34] , glycemic control is dependent on the number of islets transplanted. When more is islets are transplanted, better control is achieved. A combination of CnP and BTC-δ4 is an effective tool in obtaining a large number of β cells in vitro from progenitor cells.
